Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer-Reference-Cited by-同舟云学术

Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer

Published:2022-10-25 Issue:3 Volume:196 Page:505-515
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lobanova Olga^ORCID,Medvedieva Nataliia^ORCID,Fishchuk Liliia^ORCID,Dubitska Olha^ORCID,Cheshuk Valeriy^ORCID,Vereshchako Roman^ORCID,Zakhartseva Liubov^ORCID,Rossokha Zoia^ORCID,Gorovenko Natalia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06774-2.pdf

Reference70 articles.

1. Illum LRH, Bak ST, Lund S et al (2018) DNA methylation in epigenetic inheritance of metabolic diseases through the male germ line. J Mol Endocrinol 60:R39–R56. https://doi.org/10.1530/JME-17-0189

2. Cho YH, McCullough LE, Gammon MD et al (2015) Promoter hypermethylation in white blood cell DNA and breast cancer risk. J Cancer 6:819–824. https://doi.org/10.7150/jca.12174

3. Lønning PE, Berge EO, Bjørnslett M et al (2018) Blood cell BRCA1 promoter methylation status and ovarian cancer risk. Ann Intern Med 168:326–334. https://doi.org/10.7326/M17-0101

4. Ruscito I, Gasparri ML, De Marco MP et al (2021) The clinical and pathological profile of BRCA1 gene methylated breast cancer women: a meta-analysis. Cancers (Basel) 13:1391. https://doi.org/10.3390/cancers13061391

5. Stefansson OA, Villanueva A, Vidal A et al (2012) BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Epigenetics 7:1225–1229. https://doi.org/10.4161/epi.22561

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer;Cancer Biomarkers;2024-08-27

2. GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS;Experimental Oncology;2024-02-03

3. Combination of 15q24 Microdeletion Syndrome and Metabolic Imbalance in a Patient with Atypical Autism;Journal of Molecular Neuroscience;2024-01-05

4. CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT;Experimental Oncology;2023-10-11

5. Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer;Journal of Cancer Research and Clinical Oncology;2023-07-07